US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AI Healthcare

677.43

+32.665.07%

Number of Gainers:4

Number of Losers:- -

Number of Flat:- -

PE:- -

High:681.69

Open:650.59

Low:646.89

Close:644.77

Volume:26.61M

Turnover:579.31M

Market Cap:20.88B

Float Cap:15.41B

Loading ...

GUIDANCE: (TEM) Tempus AI Expects 2026 Revenue of About $1.59B, vs. FactSet Est of $1.58B

MT Newswires Live

Tempus AI Q4 Adj. EPS $(0.04), Inline, Sales $367.211M Beat $362.286M Estimate

Tempus AI Inc FY2026 REV View $1.58 Bln -- Lseg Ibes Data

THOMSON REUTERS

Tempus AI Inc Revenue Guidance of $1.59 Billion for 2026

THOMSON REUTERS

ARK Unplugged: How Cathie Wood Crushed the S&P 500 in 2025

What's Going On With Beam Therapeutics Stock?

Benzinga_recent_news

tempus AI Inc Class A options imply 8.0% move in share price post-earnings

Beam Therapeutics announces $500M financing facility

Beam Therapeutics Secures $500 Million Credit Facility

Beam Therapeutics tops Q4 profit estimates, signs financing deal

Beam Q4 net income attributable to common stockholders hits USD 244.3 million

Beam Therapeutics Secures $500 Million Financing Facility With Sixth Street

Beam Therapeutics Inc - Secures up to $500 Mln Non-Dilutive Capital From Sixth Street

THOMSON REUTERS

Beam Therapeutics Inc - Plans Ind Filing for Beam-304 With FDA in 2026

THOMSON REUTERS

Beam Therapeutics Q4 License and Collaboration Revenue USD 114.109 Million

THOMSON REUTERS

Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU)

Beam Therapeutics Inc - Credit Facility Matures in 2033 With 10% Interest Rate

THOMSON REUTERS

Press Release: Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street

U.S. Stocks to Watch: Hims & Hers, IBM, BWX, Kratos, Diamondback, Vir, Home Depot, and More

Beam Therapeutics Inc. published an update to their financial calendar

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4611/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4611","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","market":"US","secType":"PLATE","nameCN":"AI Healthcare","latestPrice":677.42865,"timestamp":1771966799999,"preClose":644.76715,"halted":0,"volume":26606368,"delay":0,"changeRate":0.050656,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":32.661499,"latestTime":"02-24 16:00:00 EST","open":650.5942,"high":681.6937,"low":646.89136,"amount":579305920.929416,"amplitude":0.053977,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771981200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.506097,"peRate":-10.450035,"turnoverRate":0.038164,"increases":4,"decrements":0,"flats":0,"marketCap":20875663104,"floatMarketCap":15405434624},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","high":681.6937,"amplitude":0.053977,"preClose":644.76715,"low":646.89136,"pbRate":"4.506097","latestPrice":677.42865,"volume":26606368,"delay":0,"open":650.5942,"prevYearClose":658.3995,"prevWeekClose":644.5843,"prevMonthClose":653.7386,"prevQuarterClose":658.3995,"fiveDayClose":618.8093,"twentyDayClose":727.776,"sixtyDayClose":733.069,"secType":"PLATE","market":"US","turnoverRate":0.038164,"peRate":-10.450035,"marketCap":20875663104,"floatMarketCap":15405434624,"timestamp":1771966799999,"nameCN":"AI Healthcare"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4611\",,,,undefined,":{"bkCode":"BK4611","up":4,"down":0,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4611\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2614728653","title":"GUIDANCE: (TEM) Tempus AI Expects 2026 Revenue of About $1.59B, vs. FactSet Est of $1.58B","url":"https://stock-news.laohu8.com/highlight/detail?id=2614728653","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614728653?lang=en_us&edition=fundamental","pubTime":"2026-02-25 05:13","pubTimestamp":1771967606,"startTime":"0","endTime":"0","summary":"GUIDANCE: (TEM) Tempus AI Expects 2026 Revenue of About $1.59B, vs. FactSet Est of $1.58B","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TEMT","LU1861558580.USD","LU1861559042.SGD","BK7095","BK4121","BK4611","BK4613","TEM"],"gpt_icon":0},{"id":"2614740657","title":"Tempus AI Q4 Adj. EPS $(0.04), Inline, Sales $367.211M Beat $362.286M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2614740657","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614740657?lang=en_us&edition=fundamental","pubTime":"2026-02-25 05:03","pubTimestamp":1771966994,"startTime":"0","endTime":"0","summary":"Tempus AI (NASDAQ:TEM) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is a 77.78 percent increase over losses of $(0.18) per share from the same period last year.  The","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50832290/tempus-ai-q4-adj-eps-0-04-inline-sales-367-211m-beat-362-286m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Tempus AI Q4 Adj. EPS $(0.04), Inline, Sales $367.211M Beat $362.286M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEMT","BK4611","LU1861558580.USD","BK4613","TEM","LU1861559042.SGD","BK4121"],"gpt_icon":1},{"id":"2614740580","title":"Tempus AI Inc  FY2026 REV View $1.58 Bln -- Lseg Ibes Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2614740580","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614740580?lang=en_us&edition=fundamental","pubTime":"2026-02-25 05:01","pubTimestamp":1771966861,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nPLX62DDC9:10","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TEMT","TEM","BK4613","LU1861558580.USD","LU1861559042.SGD","BK4611","BK4121"],"gpt_icon":0},{"id":"2614403507","title":"Tempus AI Inc Revenue Guidance of $1.59 Billion for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2614403507","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614403507?lang=en_us&edition=fundamental","pubTime":"2026-02-25 05:01","pubTimestamp":1771966861,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nPLX62DDC9:9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1861559042.SGD","TEMT","LU1861558580.USD","BK4121","TEM","BK4611","BK4613"],"gpt_icon":0},{"id":"2614874086","title":"ARK Unplugged: How Cathie Wood Crushed the S&P 500 in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2614874086","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614874086?lang=en_us&edition=fundamental","pubTime":"2026-02-25 04:52","pubTimestamp":1771966320,"startTime":"0","endTime":"0","summary":"ARK's 2025 winners included Robinhood, AMD and Palantir, while its losers were The Trade Desk, Recursion and Twist.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/24/Los-Angeles--California---July-6-2025-Ar.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/24/Los-Angeles--California---July-6-2025-Ar.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/markets/tech/26/02/50831831/ark-unplugged-how-cathie-wood-crushed-the-sp-500-in-2025","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/tech/26/02/50831831/ark-unplugged-how-cathie-wood-crushed-the-sp-500-in-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4585","LU0889565833.HKD","SH","BK4547","AMYY","HOOG","BK4550","AMDY","LU0823434740.USD","LU2458330169.SGD","SPLV","LU1242518857.USD","BK4504","UPRO","HOOW","LU2355687059.USD","OEF","BK4532","OEX","BK4605","SPXS","HODU","LU0198837287.USD","LU1880398554.USD","LU2264538146.SGD","LU1988902786.USD","LU0642271901.SGD","ARKK","AMUU","LU1303367103.USD","LU1803068979.SGD","LU0056508442.USD","IVW","ESmain","HOII","BK4575","AMDG","LU1951198990.SGD","BK4512","LU2054465674.USD","AMDD","IVV","LU1064131342.USD","LU1852331112.SGD","BK4544","VOOV","IE00B5949003.HKD","LU1951200564.SGD","LU1861559042.SGD","BK4127","AMDW","BK4612","SPDN","HOOX","LU2089985449.USD","VTI","BK4141","BK4534","LU0823434583.USD","SPYI","BK4614","AMDU","LU0109392836.USD","LU0274383776.USD","LU2360106780.USD","HOOY","SPYV","LU1923623000.USD","SPXU","IE00BMPRXR70.SGD","LU0390134368.USD","LU0082616367.USD","BK4543","LU0823421416.USD","SPYM","BK4529","LU2458330243.SGD","SPXL","LU1861558580.USD","BK4573","BK4566","MESmain","IE00BMPRXN33.USD","BK4611","DAMD","IE0004445239.USD","BMAY","BK4559","HOOD","XDTE","AMD","LU0081259029.USD","HOOZ","BK4548","GPIX","LU0979878070.USD","BK4581","LU0719512351.SGD","HOOI","BK4539","IE0009356076.USD","ROBN","IVOO","BK4588","BK4554","LU1989764664.SGD","LU1242518931.SGD","LU2250418816.HKD","LU1316542783.SGD","HIBL","LU0823421333.USD","BK4139","SSO","LU2098885051.SGD","HOYY","LU1880398471.USD","BK4609","LU0127658192.USD","LU2931357623.SGD","SDS"],"gpt_icon":1},{"id":"2614474406","title":"What's Going On With Beam Therapeutics Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2614474406","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614474406?lang=en_us&edition=fundamental","pubTime":"2026-02-25 03:07","pubTimestamp":1771960020,"startTime":"0","endTime":"0","summary":"Beam Therapeutics (NASDAQ: BEAM) shares are rising Tuesday after the company reported quarterly results.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/24/Candlestick-Chart-Showing-Falling-Stock-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/24/Candlestick-Chart-Showing-Falling-Stock-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/26/02/50828406/whats-going-on-with-beam-therapeutics-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/02/50828406/whats-going-on-with-beam-therapeutics-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4505","LU1861558580.USD","BEAM","LU1861559042.SGD","BK4007","BK4139","BK4556","BK4585","BK4588","BK4611","BK4535","IND","LENZ","BK4539"],"gpt_icon":0},{"id":"2614428587","title":"tempus AI Inc Class A options imply 8.0% move in share price post-earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2614428587","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614428587?lang=en_us&edition=fundamental","pubTime":"2026-02-25 03:05","pubTimestamp":1771959917,"startTime":"0","endTime":"0","summary":"Pre-earnings options volume in tempus AI (TEM) Inc Class A is normal with calls leading puts 2:1. Implied volatility suggests the market is anticip...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-inc-class-a-options-imply-8-0-move-in-share-price-post-earnings-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-inc-class-a-options-imply-8-0-move-in-share-price-post-earnings-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AIYY","BK4588","BK4551","BK4587","AI","LU1861559042.SGD","BK4543","LU1861558580.USD","BK4611","TEMT","BK4528","BK4121","BK4613","BK4023","TEM","BK4585"],"gpt_icon":0},{"id":"2613719141","title":"Beam Therapeutics announces $500M financing facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2613719141","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613719141?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:36","pubTimestamp":1771936616,"startTime":"0","endTime":"0","summary":"Beam Therapeutics (BEAM) entered into a strategic financing agreement with Sixth Street for substantial, long-term, non-dilutive capital to fund th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beam-therapeutics-announces-500m-financing-facility-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beam-therapeutics-announces-500m-financing-facility-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861558580.USD","LU1861559042.SGD","BK4611","BK4539","BK4588","BK4556","BK4585","BK4535","BEAM","LENZ","BK4007","BK4505","BK4139"],"gpt_icon":0},{"id":"2613173719","title":"Beam Therapeutics Secures $500 Million Credit Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2613173719","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613173719?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:35","pubTimestamp":1771936513,"startTime":"0","endTime":"0","summary":"Beam Therapeutics ( ($BEAM) ) has shared an update. On February 24, 2026, Beam Therapeutics reported fourth-quarter and full-year 2025 financial re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beam-therapeutics-secures-500-million-credit-facility?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beam-therapeutics-secures-500-million-credit-facility?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4611","BK4007","LU1861559042.SGD","BK4539","BK4139","BK4505","BK4556","BK4585","BEAM","LU1861558580.USD","BK4588","BK4535"],"gpt_icon":0},{"id":"2613846716","title":"Beam Therapeutics tops Q4 profit estimates, signs financing deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2613846716","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613846716?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:10","pubTimestamp":1771935052,"startTime":"0","endTime":"0","summary":"Beam Therapeutics tops Q4 profit estimates, signs financing dealOverviewBiotechnology firm reported Q4 EPS and net income beat analyst expectationsCompany entered strategic financing agreement with Si","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL1N3ZK0HD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861559042.SGD","LU1861558580.USD","BK4535","BK4611","BK4556","BK4585","BK4505","BK4588","BEAM","BK4139"],"gpt_icon":0},{"id":"2613471529","title":"Beam Q4 net income attributable to common stockholders hits USD 244.3 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2613471529","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613471529?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:05","pubTimestamp":1771934720,"startTime":"0","endTime":"0","summary":"Beam Q4 net income attributable to common stockholders hits USD 244.3 million               Beam Therapeutics reported Q4 2025 license and collaboration revenue of USD 114.1 million (up 279.5%) and R&","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDLcfW8ZH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","LU2210150020.SGD","IE00BKPKM429.USD","BK4585","LU1861558580.USD","LU2095319765.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","BK4611","SG9999014005.SGD","LU2210149790.SGD","BK4139","SG9999014013.SGD","LU1861559042.SGD","BK4556","BEAM","SG9999014039.USD","BK4588","BK4505","BK4112","LU0314104364.USD","IE00BGHQF748.EUR","NDAQ","SG9999014021.USD"],"gpt_icon":0},{"id":"2613771591","title":"Beam Therapeutics Secures $500 Million Financing Facility With Sixth Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2613771591","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613771591?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:03","pubTimestamp":1771934629,"startTime":"0","endTime":"0","summary":"Beam Therapeutics Inc. entered a $500 million senior secured credit facility with Sixth Street to support the potential launch of its sickle cell disease therapy risto-cel. The facility includes $100 million funded at closing, up to $300 million available upon specified clinical, regulatory and commercial milestones, and an additional $100 million available at Beam’s option subject to mutual agreement. The seven-year facility matures in early 2033, carries an interest rate of about 10% based on current SOFR projections, has no scheduled amortization, and is secured by first-priority liens on substantially all of Beam’s assets.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL6dySKt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","LU2210150020.SGD","IE00BKPKM429.USD","BK4585","LU1861558580.USD","LU2095319765.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","BK4611","SG9999014005.SGD","LU2210149790.SGD","BK4139","SG9999014013.SGD","LU1861559042.SGD","BK4556","BEAM","SG9999014039.USD","BK4588","BK4505","BK4112","LU0314104364.USD","IE00BGHQF748.EUR","NDAQ","SG9999014021.USD"],"gpt_icon":0},{"id":"2613971684","title":"Beam Therapeutics Inc - Secures up to $500 Mln Non-Dilutive Capital From Sixth Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2613971684","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613971684?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:01","pubTimestamp":1771934461,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nPLX183866:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1861559042.SGD","BK4611","LU1861558580.USD","BK4556","BK4588","BK4505","BK4139","BK4585","BEAM","BK4535"],"gpt_icon":0},{"id":"2613716801","title":"Beam Therapeutics Inc - Plans Ind Filing for Beam-304 With FDA in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2613716801","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613716801?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:01","pubTimestamp":1771934461,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nPLX183866:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4585","BK4535","BK4611","LU1861558580.USD","BK4556","LU1861559042.SGD","BEAM","BK4139","BK4588"],"gpt_icon":0},{"id":"2613715575","title":"Beam Therapeutics Q4 License and Collaboration Revenue USD 114.109 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2613715575","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613715575?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:01","pubTimestamp":1771934461,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nPLX183866:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4585","BK4611","BEAM","BK4556","BK4588","LU1861559042.SGD","LU1861558580.USD","BK4139","BK4535"],"gpt_icon":0},{"id":"2613559719","title":"Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2613559719","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613559719?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:01","pubTimestamp":1771934460,"startTime":"0","endTime":"0","summary":"New Program Designed as Platform-based Approach for Direct Correction of Mutations Causing PKU; Investigational New Drug (IND) Filing for BEAM304 Anticipated in 2026 Updated Phase 1/2 Data and Next St","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/24/3243386/0/en/Beam-Therapeutics-Reports-Fourth-Quarter-and-Year-End-2025-Financial-Results-and-Announces-New-Liver-Targeted-Genetic-Disease-Program-in-Phenylketonuria-PKU.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861559042.SGD","LU0122379950.USD","BK4533","LU0306806265.USD","SCD","LU0321505439.SGD","SGXZ57979304.SGD","BK4581","LENZ","LU1894683264.USD","BK4505","SG9999001176.USD","LU0225284248.USD","BK4109","BEAM","BK4588","SG9999002224.SGD","BK4556","SG9999002232.USD","BK4535","BK4139","LU0170899867.USD","BK4568","BK4534","LU1894683348.USD","LU0306807586.USD","SG9999001176.SGD","BK4611","LU0289739699.SGD","BK4592","LU1066051498.USD","IE00BBT3K403.USD","BK4539","SG9999011175.SGD","LU0321505868.SGD","LU0868494617.USD","IND","IE000M9KFDE8.USD","LU1023059063.AUD","BK4550","LU0234572021.USD","LU1861558580.USD","LU1883839398.USD","SG9999013999.USD","ASH","BK4599","IE00B19Z3B42.SGD","BK4585","LU0456855351.SGD"],"gpt_icon":1},{"id":"2613716893","title":"Beam Therapeutics Inc - Credit Facility Matures in 2033 With 10% Interest Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2613716893","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613716893?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:00","pubTimestamp":1771934402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nTUA1CVW5J:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1861559042.SGD","BK4139","BK4585","BK4588","BK4505","LU1861558580.USD","BEAM","BK4556","BK4535","BK4611"],"gpt_icon":0},{"id":"2613571540","title":"Press Release: Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2613571540","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613571540?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:00","pubTimestamp":1771934400,"startTime":"0","endTime":"0","summary":"$100 Million Funded at Close with up to an Additional $400 Million Available Under Facility with Seven-Year Term. Financing Bolsters Balance Sheet with Long-term, Non-dilutive Capital to Support Anticipated Launch of Risto-cel in Sickle Cell Disease . The credit facility matures in early 2033 and bears interest at an annual rate of approximately 10% based on current forward projections for SOFR. The facility does not provide for scheduled amortization payments, and all principal amounts will be due at maturity in early 2033. Beam may prepay loans under the credit facility at any time, subject to customary yield maintenance and prepayment premiums during the early years of the facility. The company is expecting to draw a minimum of $200 million of capital under the overall facility and make mandatory prepayments from certain non-ordinary course proceeds, including proceeds from non-permit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4535","BK4505","LU1861559042.SGD","BK4585","BK4007","BK4588","LU1861558580.USD","LENZ","SCD","BK4139","BEAM","BK4556","BK4611"],"gpt_icon":0},{"id":"1104634197","title":"U.S. Stocks to Watch: Hims & Hers, IBM, BWX, Kratos, Diamondback, Vir, Home Depot, and More","url":"https://stock-news.laohu8.com/highlight/detail?id=1104634197","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104634197?lang=en_us&edition=fundamental","pubTime":"2026-02-24 19:04","pubTimestamp":1771931049,"startTime":"0","endTime":"0","summary":"Stock futures were edging higher on Tuesday as investors tried to make sense of another brutal artificial-intelligence selloff.These stocks were making moves in premarket trading:$Hims & Hers...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4108","BK4187","BK4213","BK4579","LU0310800965.SGD","LU1989763005.USD","LU1989772923.USD","LU0823421416.USD","BK4550","BK7501","LU1430594728.SGD","IE00B5949003.HKD","BK4106","LU2347655073.USD","KTOS","BK4533","BK4588","LU1732799900.SGD","LU1914381329.SGD","LU1046421795.USD","BK4219","FANG","IE00BD4GTW91.USD","LU0823411888.USD","LU0354030511.USD","LU1929549753.HKD","AMC","LU2506951792.HKD","BK4515","BK4575","LU0823434583.USD","LU0795875086.SGD","LU2265009873.SGD","LU0949170772.SGD","LU0109391861.USD","LU0082616367.USD","LU0719512351.SGD","LU1894683264.USD","BK4227","LU1548497426.USD","BK4208","LU1585245621.USD","BK4141","LU2272731782.SGD","LU2357305700.SGD","BK4554","HD","LU1236620750.USD","LU2095319765.USD","LU2211814178.USD","LU2361044865.SGD","LU0823434740.USD","BK4566","LU0823421333.USD","CSGP","LU0672654240.SGD","LU1551013425.SGD","LU0820561909.HKD","WHR","IE00B3CCJ633.GBP","TEMT","BK4139","IE00BMPRXN33.USD","LU0942090050.USD","LU1169590202.USD","LU2756315318.SGD","HIMS","BK4083","BWXT","LU1093756168.USD","IE00BD4GTV84.USD","LU1804176565.USD","BK4170","IE00B2PGVK34.USD","LU0868494617.USD","LU1992135472.HKD","LU1935042991.SGD","BK4157","BK4177","KEYS","LU2361044949.HKD","BK4602","BK7063","LU1883839398.USD","LU2360107671.USD","LU0320765059.SGD","LU2322448791.USD","IE00BSNM7G36.USD","LU1917777945.USD","LU1989772840.SGD","LU0742534661.SGD","BK4191","BK4121","LU0077335932.USD","LU0124384867.USD","LU0980610538.SGD","LU2249611893.SGD","IE00BD6J9T35.USD","LU1162221912.USD","LU1992135399.USD","BK4079","BK4547","BK4519","IE00BGHQF524.EUR","BWX","LU0345774391.USD","LU1989763427.SGD","LU0689472784.USD","LU0130517989.USD","LU1035775433.USD","LU0048573561.USD","LU0321505439.SGD","LU2461242641.AUD","LU2517655291.USD","LU1880398554.USD","BK4084","LU0477156953.USD","LU0320765646.SGD","LU0868494708.USD","LU1201861249.SGD","BK4504","LU0724618433.USD","BK4611","BK4538","LU0312595415.SGD","LU1235294995.USD","LU0795875169.SGD","LU2756315664.SGD","IE00BGHQF417.EUR","SG9999001440.SGD","BK4567","LU0823414478.USD","LU1861217088.USD","LU0128525689.USD","BK4528","FIS","LU0708995401.HKD","BK7007","AMT","IE00BJTD4N35.SGD","LU1267930227.SGD","IE00BZ1G4Q59.USD","LU1668664300.SGD","IBM","LU2125909593.SGD","BK7095","LU1496350502.SGD","LU2210150020.SGD","BK4568","IE0004445239.USD","PLNT","LU0162691827.USD","BK4023","LU1732800096.USD","LU2048586759.USD","IE00BKVL7J92.USD","SG9999000418.SGD","BK4585","LU2517655028.SGD","BK4535","LU1551013342.USD","LU1989763690.USD","LU2298322129.HKD","TEM","LU0820562030.AUD","CNP","BK4581","LU0072461881.USD","LU1923622614.USD","LU1778281490.HKD","LU0912757837.SGD","BK4169","LU1983299162.USD","IE00BD4GTT62.SGD","LU2279689827.SGD","LU1691799644.USD","BK4123","LU0820561818.USD","LU0648001328.SGD","BK4534","LU2023250504.SGD","LU2272731865.HKD","LU0661504455.SGD","LU2473716301.USD","BK4596","LU2517655374.HKD","LU0251142724.SGD","LU0106831901.USD","LU1989773731.SGD","KDP","LU0354030438.USD","LU0345774631.USD","BK4216","LU0238689110.USD","LU0154245673.USD","AXON","LU0738911758.USD","LU1720051017.SGD","LU0052756011.USD","BK4613","LU1974910355.USD","LU2211815571.USD","BK4543","LU0323239441.USD","LU0107464264.USD","LU1267930730.SGD","LU2357125470.USD","BK4505","LU0079474960.USD","LU1894683348.USD","LU0726765562.USD","IE0009356076.USD","LU1093756325.SGD","LU1935043536.SGD","AI","LU1978683503.SGD","LU2063271972.USD","LU2125909247.SGD","LU2347655156.SGD","HPQ","LU2210149790.SGD","LU1236620834.HKD","WDAY","LU1861220207.SGD","LU0251131958.USD","LU2294711713.HKD","LU0943347566.SGD","BK4007","LU1861559042.SGD","LU1496350171.SGD","LU1720051108.HKD","LU2361045086.USD","IE00BMPRXR70.SGD","LU1069344957.HKD","LU0321505868.SGD","VIR","IE00BN0W2W23.USD","IE00B1XK9C88.USD","LU0154245756.USD","LU0234572021.USD","IE00BJTD4V19.USD","FSLR","LU1674673428.USD","LU2380233275.USD","LU0130102774.USD","IE00BN0W2V16.EUR","LU1823568750.SGD","LU1674673691.USD","IE00B3CCJ963.GBP","DUG","LU1880398471.USD","LU0823414551.USD","LU2106854487.HKD","LU2272731600.USD","LU0006061336.USD","LU1169589451.USD","LU0053671581.USD","IE00BWXC8680.SGD","BK4612","BK4134","LU1861558580.USD","LU0266013472.USD","IE00B2Q91V27.USD","LU0314104364.USD","LU0390134368.USD","LU2133065610.SGD","LU2322448957.HKD","IE00BN0W2T93.GBP","BK4548","LU0323240290.USD"],"gpt_icon":1},{"id":"2613382737","title":"Beam Therapeutics Inc. published an update to their financial calendar","url":"https://stock-news.laohu8.com/highlight/detail?id=2613382737","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613382737?lang=en_us&edition=fundamental","pubTime":"2026-02-24 05:00","pubTimestamp":1771880411,"startTime":"0","endTime":"0","summary":"Beam Therapeutics Inc. will announce its fourth quarter and full year 2025 financial results and a new liver-targeted genetic disease program on an investor webcast on Tuesday, February 24, 2026, at 8:00 a.m. ET. The live webcast will be available in the investor section of www.beamtx.com and will be archived for 60 days.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beam Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on February 23, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDLbWPf2X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","SG9999014021.USD","LU1861558580.USD","BEAM","BK4556","LU1861559042.SGD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU0314104364.USD","LU2210150020.SGD","BK4611","IE00B64PRP62.GBP","LU2210149790.SGD","BK4505","SG9999014039.USD","BK4588","IE00BKPKM429.USD","BK4139","SG9999014013.SGD","LU2095319765.USD","NDAQ","SG9999014005.SGD","BK4585","BK4112"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":65,"code":"91000000","status":"200"}]}}